Keensight Capital opens US office

Its new US office also confirms its commitment to supporting the growth of its portfolio companies in North America, the firm said in a statement.

The GP chose Boston as its first US base due to the city’s technology and healthcare industry hubs, as well as its numerous universities. Its northeastern location also provides easy access to London and Paris, where Keensight already has offices.

Keensight invests in European businesses with revenues of EUR 10m-EUR 400m. Its latest fundraise was for Keensight Capital V, which held a final close in March 2019 on EUR 1bn, surpassing its EUR 750m target. The vehicle deploys equity tickets of EUR 20m-EUR 200m, according to Unquote Data.

The GP’s recent investments include Germany-based online procurement platform Onventis, which it acquired from Main Capital Partners in January 2023. In April this year, it acquired Spain-based inhalation active pharmaceutical ingredients (APIs) developer Inke from parent company Neuraxpharm.

The firm’s most recent exit was ASTI, a Spain-based autonomous mobile robot (AMR) manufacturer, which it sold to ABB in 2021. Keensight portfolio companies that have a high score within Mergermarket’s Likely to Exit (LTE) predictive algorithm include France-based temporary and flexible employment provider Pixid, which has a score of 57 and was acquired by Keensight in 2015.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• GPs
• People
• UK / Ireland
• people moves
• Keensight Capital
• US